Fig. 1: Analyzing ICER trends: Impact of patient volume and number of pediatric endocrine sites within a health system.
From: Cost-effectiveness of AI for pediatric diabetic eye exams from a health system perspective

This graph illustrates the necessary annual screening volume (x-axis) and health system size (indicated by line color) for the autonomous AI screening strategy to be cost-effective compared to the ECP strategy. ICER values falling below the willingness-to-pay (WTP) threshold of $413 (dashed line) indicate that the autonomous AI strategy is cost-effective.